Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-25 | New | $6,000,000 | $6,000,000 | Equity Only | 06b | SEC link |
| 2019-03-08 | New | $2,500,000 | $2,500,000 | Equity Only | 06b | SEC link |
| 2013-02-04 | New | $6,000,000 | $6,000,000 | Debt Only | 06 | SEC link |
| 2010-07-26 | New | Yet to Sell | $0 | Equity Only | 06 46 | SEC link |
| 2008-10-06 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2007-06-15 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2007-06-15 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Milton Boniuk | Director |
| Zucker Brian | Director |
| Anil Diwan | Director, Executive |
| Stanley Glick | Director |
| Makarand Jawadekar | Director |
| Mukund Kulkarni | Director |
| Theodore Edward Rokita | Director |
| Eugene Seymour | Director, Executive |
| Eugene Seymour, M.D. | Director, Executive |
| Meeta Vyas | Executive |